Search

Author/Creator Maria Langkilde, Anna

1. Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial. Issue 16 (27th August 2022)

Authors:
Butt, Jawad H.; Jhund, Pardeep S.; Belohlávek, Jan; de Boer, Rudolf A.; Chiang, Chern-En; Desai, Akshai S.; Drożdż, Jarosław; Hernandez, Adrian F.; Inzucchi, Silvio E.; Katova, Tzvetana; Kitakaze, Masafumi; Kosiborod, Mikhail N.; Lam, Carolyn S.P.; Maria Langkilde, Anna; Lindholm, Daniel; Bachus,...
Journal:
Circulation
Issue:
Volume 146:Issue 16(2022)
Page Start:
1210
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial. (22nd November 2021)

Authors:
Butt, Jawad H.; Adamson, Carly; Docherty, Kieran F.; de Boer, Rudolf A.; Petrie, Mark C.; Inzucchi, Silvio E.; Kosiborod, Mikhail N.; Maria Langkilde, Anna; Lindholm, Daniel; Martinez, Felipe A.; Bengtsson, Olof; Schou, Morten; O'Meara, Eileen; Ponikowski, Piotr; Sabatine, Marc S.; Sjöstrand, Mik...
Journal:
Circulation
Issue:
Volume 14:Number 12(2021)
Page Start:
e008837
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial. (December 2021)

Authors:
Butt, Jawad H.; Adamson, Carly; Docherty, Kieran F.; de Boer, Rudolf A.; Petrie, Mark C.; Inzucchi, Silvio E.; Kosiborod, Mikhail N.; Maria Langkilde, Anna; Lindholm, Daniel; Martinez, Felipe A.; Bengtsson, Olof; Schou, Morten; O'Meara, Eileen; Ponikowski, Piotr; Sabatine, Marc S.; Sjöstrand, Mik...
Journal:
Circulation
Issue:
Volume 14:Number 12(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FC082: Effects of Dapagliflozin in Patients with Chronic Kidney Disease According to Background Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dose. (3rd May 2022)

Authors:
Lambers Heerspink, Hiddo; Jong, Niels; Stefansson, Bergur; Chertow, Glenn; Maria Langkilde, Anna; Mcmurray, John; Correa-Rotter, Ricardo; Rossing, Peter; Toto, Robert; Wheeler, David
Journal:
Nephrology dialysis transplantation
Issue:
Volume 37(2022)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗